Top

Published in:

01-08-2007

RAGE Activation by S100P in Colon Cancer Stimulates Growth, Migration, and Cell Signaling Pathways

Authors: Maren K. Fuentes, M.S., Shraddha S. Nigavekar, Ph.D., Thiruvengadam Arumugam, Ph.D., Craig D. Logsdon, Ph.D., Ann Marie Schmidt, M.D., Juliet C. Park, M.D., Emina H. Huang, M.D.

Published in: Diseases of the Colon & Rectum | Issue 8/2007

Purpose

Colon cancer is the third most prevalent cancer in the United States. However, the molecular mechanisms involved in the development and progression of colon cancer are incompletely understood. This study was initiated to explore the potential role of the receptor for advanced glycation end-products and S100P in modulation of key properties of human colon cancer cells.

Methods

Western blot, reverse transcription-polymerase chain reaction, and quantitative polymerase chain reaction were performed for detection of the receptor for advanced glycation end-products and S100P in colon cancer and matched normal colon. The influence of exogenously added S100P was analyzed on SW480 colon cancer cell line proliferation, migration, phosphorylation of mitogen activated protein kinases, and NFκB activation. To identify the mechanisms involved in these responses, coimmunoprecipitation examining the S100P/Receptor for advanced glycation end-products interaction and the effects of receptor for advanced glycation end-products inhibition in this interaction were analyzed.

Results

Although the receptor for advanced glycation end-products was present in normal and malignant colon specimens, only the malignant specimens expressed S100P. Treatment of SW480 cells with S100P increased proliferation and cell migration. Addition of exogenous S100P stimulated both ERK1/2 phosphorylation and NFκB activity. The interaction between S100P and the receptor for advanced glycation end-products was demonstrated by coimmunoprecipitation of these molecules from SW480 cells. Antagonism of the receptor for advanced glycation end-products blocked this interaction and the biologic effects of S100P on these cells.

Conclusions

These data indicate that S100P is expressed at greater levels in colon cancer than matched normal tissue and that S100P stimulates colon cancer cell growth, migration, Erk phosphorylation, and NFκB activation in vitro, suggesting that this ligand/receptor pair may be targeted for the development of new therapies.

Chorost, MI, Datta, R, Santiago, RC, et al. 2004Colon cancer screening: where have we come from and where do we go?J Surg Oncol85713PubMedCrossRef

Huycke, MM, Gaskins, HR 2004Commensal bacteria, redox stress, and colorectal cancer: mechanisms and modelsExp Biol Med229586597

Fearon, ER, Vogelstein, B 1990A genetic model for colorectal tumorigenesisCell61759767PubMedCrossRef

Smith, G, Carey, FA, Beattie, J, et al. 2002Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancerProc Natl Acad Sci USA9994339438PubMedCrossRef

Neeper, M, Schmidt, AM, Brett, J, et al. 1992Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteinsJ Biol Chem2671499815004PubMed

Hori, O, Brett, J, Slattery, T, et al. 1995The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous systemJ Biol Chem2702575225761PubMedCrossRef

Yan, S, Zhu, H, Fu, J, et al. 1997Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer diseaseProc Natl Acad Sci USA9452965301PubMedCrossRef

Hofmann, MA, Drury, S, Fu, C, et al. 1999RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptidesCell97889901PubMedCrossRef

Schmidt, AM, Yan, SD, Yan, SF, Stern, DM 2001The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responsesJ Clin Invest108949955PubMedCrossRef

10.

Stern, DM, Yan, SD, Yan, SF, Schmidt, AM 2002Receptor for advanced glycation endproducts (RAGE) and the complications of diabetesAgeing Res Rev1115PubMedCrossRef

11.

Taguchi, A, Blood, DC, Toro, G, et al. 2000Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastasesNature405354360PubMedCrossRef

12.

Donato, R 2001S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional rolesInt J Biochem Cell Biol33637668PubMedCrossRef

13.

Heizmann, CW, Fritz, G, Schafer, BW 2002S100 proteins: structure, functions and pathologyFront Biosci7d1356d1368PubMedCrossRef

14.

McNutt, NS 1998The S100 family of multipurpose calcium-binding proteinsJ Cutan Pathol25521529PubMedCrossRef

15.

Schafer, BW, Heizmann, CW 1996The S100 family of EF-hand calcium-binding proteins: functions and pathologyTrends Biochem Sci21134140PubMedCrossRef

16.

Zimmer, DB, Cornwall, EH, Landar, A, Song, W 1995The S100 protein family: history, function, and expressionBrain Res Bull37417429PubMedCrossRef

17.

Arumugam, T, Simeone, DM, Schmidt, AM, Logsdon, CD 2004S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)J Biol Chem27950595065PubMedCrossRef

18.

Becker, T, Gerke, V, Kube, E, Weber, K 1992S100P, a novel Ca(2+)-binding protein from human placenta. cDNA cloning, recombinant protein expression and Ca2+ binding propertiesEur J Biochem207541547PubMedCrossRef

19.

Emoto, Y, Kobayashi, R, Akatsuka, H, Hidaka, H 1992Purification and characterization of a new member of the S-100 protein family from human placentaBiochem Biophys Res Commun18212461253PubMedCrossRef

20.

Sato, N, Hitomi, J 2002S100P expression in human esophageal epithelial cells: Human esophageal epithelial cells sequentially produce different S100 proteins in the process of differentiationAnat Rec2676069PubMedCrossRef

21.

Averboukh, L, Liang, P, Kantoff, PW, Pardee, AB 1996Regulation of S100P expression by androgenProstate29350355PubMedCrossRef

22.

Logsdon, CD, Simeone, DM, Binkley, C, et al. 2003Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancerCancer Res6326492657PubMed

23.

Beer, DG, Kardia, SL, Huang, CC, et al. 2002Gene-expression profiles predict survival of patients with lung adenocarcinomaNat Med8816824PubMed

24.

Wang, G, Platt-Higgins, A, Carroll, J, et al. 2006Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patientsCancer Res6611991207PubMedCrossRef

25.

Okami, J, Simeone, DM, Logsdon, CD 2004Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancerCancer Res6453385346PubMedCrossRef

26.

Tomita, N, Jiang, W, Hibshoosh, H, et al. 1992Isolation and characterization of a highly malignant variant of the SW480 human colon cancer cell lineCancer Res5268406847PubMed

27.

Schreiber, E, Matthias, P, Muller, MM, Schaffner, W 1989Rapid detection of octamer binding proteins with “mini-extracts,” prepared from a small number of cellsNucleic Acids Res176419PubMedCrossRef

28.

Chang, F, Steelman, LS, Shelton, JG, et al. 2003Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathwayInt J Oncol22469480PubMed

29.

Pahl, HL 1999Activators and target genes of Rel/NF-kappaB transcription factorsOncogene1868536866PubMedCrossRef

30.

Kuniyasu, H, Chihara, Y, Takahashi, T 2003Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancerOncol Rep10445448PubMed

31.

Jemal, A, Clegg, LX, Ward, E, et al. 2004Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survivalCancer101327PubMedCrossRef

32.

Bierhaus, A, Schiekofer, S, Schwaninger, M, et al. 2001Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaBDiabetes5027922808PubMedCrossRef

33.

Hermani, A, Servi, B, Medunjanin, S, et al. 2006S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cellsExp Cell Res312184197PubMedCrossRef

34.

Bartling, B, Hofmann, HS, Weigle, B, et al. 2005Carcinogenesis26293301PubMedCrossRef

35.

Hsieh, HL, Schafer, BW, Sasaki, N, Heizmann, CW 2003Expression analysis of S100 proteins and RAGE in human tumors using tissue microarraysBiochem Biophys Res Commun307375381PubMedCrossRef

Title: RAGE Activation by S100P in Colon Cancer Stimulates Growth, Migration, and Cell Signaling Pathways
Authors: Maren K. Fuentes, M.S.
Shraddha S. Nigavekar, Ph.D.
Thiruvengadam Arumugam, Ph.D.
Craig D. Logsdon, Ph.D.
Ann Marie Schmidt, M.D.
Juliet C. Park, M.D.
Emina H. Huang, M.D.
Publication date: 01-08-2007
Publisher: Springer-Verlag
Published in: Diseases of the Colon & Rectum / Issue 8/2007
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI: https://doi.org/10.1007/s10350-006-0850-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

RAGE Activation by S100P in Colon Cancer Stimulates Growth, Migration, and Cell Signaling Pathways

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2007

What Proportion of Patients Referred to Secondary Care with Iron Deficiency Anemia Have Colon Cancer?

The Changing Distribution of Colorectal Cancer in Barbados: 1985–2004

The Status of Radical Proctectomy and Sphincter-Sparing Surgery in the United States

Selected Abstracts

The Effect of Restorative Proctocolectomy on Sexual Function, Urinary Function, Fertility, Pregnancy and Delivery: A Systematic Review

Adjuvant Immunochemotherapy with Protein-Bound Polysaccharide K for Colon Cancer in Relation to Oncogenic β-Catenin Activation